21 USC 360 - FDA rare neurodegenerative disease grant program

U.S. Code
title 21
chapter 9
subchapter V
part B
§ 360ee-1
notes

U.S. Code
Notes

Editorial Notes

Codification

Section was enacted as part of the Accelerating Access to Critical Therapies for ALS Act, and not as part of the Federal Food, Drug, and Cosmetic Act which comprises this chapter.